Aptose Biosciences Inc opened trading today at $2.07 and closed at $1.91. Intraday prices ranged from $1.90 to $2.07.

The price advanced 1.06% from the previous day's close of $1.89.

Today across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Aptose Biosciences Inc has listed on the Toronto Stock Exchange (TSX) under the ticker APS.

Trading volume was 7,200 on 49 total trades, with an average volume of 18,225 over 5 days.

Trading across the entire TSX saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, APS.TO has traded as high as $11.55 (April 06,2023) and low as $1.85 (March 14,2024). Moreover, the shares have shrunken -83.88% in the last 12 months, while this year, they have shrunken -42.99%.

Following today's trading, Aptose Biosciences Inc has a market capitalization of $29.71 million on a float of 15,718 shares outstanding. Its annual EPS is $-7.58.

Aptose Biosciences Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 3.00 analysts, Aptose Biosciences Inc gets an average recommendation of "Strong Buy" according to Zacks. Currently, there are 3 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..